SCHEMBL2369261

SCHEMBL2369261

CCOC(=O)Cc1nc(NCc2cccc(C)n2)c2c(-c3ccc4c(c3)OCO4)csc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
PRKCI P41743 1/20 0.43
PRKCZ Q05513 1/20 0.43
MAPT P10636 5/20 0.41
TDP1 Q9NUW8 4/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
TSHR P16473 3/20 0.41
ALDH1A1 P00352 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TP53 P04637 2/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 4/20 0.38
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2D6 P10635 3/20 0.38
MAPK1 P28482 3/20 0.38
CLK4 Q9HAZ1 2/20 0.38
CLK1 P49759 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2368514 0.90 CLK4 (0.44) SMN1; SMN2PRKCIPRKCZMAPTTDP1
SCHEMBL2368616 0.89 MEN1 (0.42) SMN1; SMN2PRKCIPRKCZMAPTTDP1
SCHEMBL3387823 0.86 KDM4E (0.40) SMN1; SMN2MAPTTDP1MEN1KMT2A
SCHEMBL3383460 0.86 PRKCZ (0.43) SMN1; SMN2PRKCIPRKCZMAPTTDP1
SCHEMBL2368333 0.86 TSHR (0.43) SMN1; SMN2MAPTTDP1MEN1KMT2A
SCHEMBL2369471 0.85 ALDH1A1 (0.47) SMN1; SMN2PRKCZMAPTTDP1MEN1
SCHEMBL2369002 0.82 ESR1 (0.48) SMN1; SMN2MAPTTDP1MEN1KMT2A
SCHEMBL2368271 0.81 PRKCZ (0.52) SMN1; SMN2PRKCIPRKCZMAPTTDP1
SCHEMBL2369291 0.80 CYP1A2 (0.41) SMN1; SMN2PRKCIPRKCZMAPTTDP1
SCHEMBL2368958 0.80 CYP1A2 (0.41) SMN1; SMN2MAPTTDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022076-B2 Thieno[2,3-d]pyrimidine derivatives as potassium channel modulators; antiarrhythmia agents XENTION LIMITED (GB) 2011-09-20 US disclosed
EP-1641803-B3 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS XENTION LTD (GB) 2010-12-08 EP disclosed
EP-1641803-B1 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS XENTION LTD (GB) 2009-03-18 EP disclosed
EP-1641803-A1 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS Xention Discovery Limited (GB) 2006-04-05 EP disclosed
WO-2004111057-A1 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS XENTION DISCOVERY LIMITED (GB) 2004-12-23 WO disclosed